dexamethasone,lenalidomide,bortezomib
takeda
['mds', 'determination', 'aml,(-streamline),(-seamless),(-kamloops)', 'mmsm']
ph3 determination presented by dr. paul richardson at #asco22 plenary! - mpfs of upfront rvd+asct &gt; rvd alone (67.5 v 46.2mo), but alarmingly more t-aml/mds (2.7% v 0%)!
- mrd-neg had similar pfs regardless of tx
- more diverse enrollment (19% african american) #mmsm #bmtsm 
Hematology/Oncology Fellow @DukeCancer | Cell Therapies, Stem Cell Transplant, ctDNA | Tweets ? med advice | Alum @NU_IntMed @UChiPritzker @Yale